What is NuCana PLC (NCNA) stock price today?

NuCana PLC (NCNA) currently trades at $2.13 per share. The stock has a market capitalization of $9.20M and a P/E ratio of 0.00x.

Is NCNA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, NuCana PLC has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is -25.10.

Is NuCana PLC financially healthy?

NuCana PLC's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of -25.10 places it in the distress.

NCNA

NuCana PLC

NASDAQ: NCNA · HEALTHCARE · BIOTECHNOLOGY

$2.13

+4.41% today

Updated 2026-04-30

Market cap

$9.20M

P/E ratio

0.00

P/S ratio

—

EPS (TTM)

$0.00

Dividend yield

—

52W range

$1 – $250

Volume

0.0M

Market cap

$9.20M

P/E ratio

0.00

P/S ratio

—

EPS (TTM)

$0.00

Dividend yield

—

52W range

$1 – $250

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-25.1

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$104.00

+4782.63%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -25.10 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-979998.00

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-32.02M	$-27.63M	$-19.00M	$-28.71M	$-2.45M
EPS	—	—	—	—	$0.00
Free cash flow	$-23.68M	$-26.92M	$-19.41M	$-7.15M	$-979998.00
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
NCNA	$9.20M	26	4.3	3.0	5.0	6.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

NuCana PLC trades at $2.13. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -25.10, it sits in the distress.

Frequently asked questions

What is NuCana PLC's stock price?

NuCana PLC (NCNA) trades at $2.13.

Is NuCana PLC overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of NuCana PLC (NCNA)?

The analyst target price is $104.00, representing +4782.6% upside from the current price of $2.13.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

-25.10 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-193.90%

Beta1.80

50D MA$1.95

200D MA$3.90

Shares out0.00B

Float20.81B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

NCNA vs LLY →NCNA vs JNJ →NCNA vs ABBV →Stock screener →